Tandem Diabetes Care Stock Price, News & Analysis (NASDAQ:TNDM)

$2.48 -0.03 (-1.20 %)
(As of 12/13/2017 04:00 PM ET)
Previous Close$2.51
Today's Range$2.48 - $2.60
52-Week Range$2.15 - $30.00
Volume80,554 shs
Average Volume200,707 shs
Market Capitalization$25.09 million
P/E RatioN/A
Dividend YieldN/A
Beta0.17

About Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care logoTandem Diabetes Care, Inc. is a medical device company. The Company is engaged in designing, developing and commercializing products for people with insulin-dependent diabetes. The Company manufactures and sells three insulin pump products, which include t:slim Insulin Delivery System (t:slim), t:flex Insulin Delivery System (t:flex) and t:slim G4 Insulin Delivery System (t:slim G4). Its technology platform features Micro-Delivery Technology, a miniaturized pumping mechanism, which draws insulin from a flexible bag within the pump's cartridge rather than relying on a syringe and plunger mechanism. It also features a software, which is a vivid color touch screen and a micro- universal serial bus (USB) connection that supports both a rechargeable battery and uploads to t:connect Diabetes Management Application (t:connect), its custom cloud-based data management application that provides display therapy management data from the pump and supported blood glucose meters.

Receive TNDM News and Ratings via Email

Sign-up to receive the latest news and ratings for TNDM and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Equipment, Supplies & Distribution
Sub-IndustryN/A
SectorMedical
SymbolNASDAQ:TNDM
CUSIPN/A
Phone858-366-6900

Debt

Debt-to-Equity Ratio-2.70%
Current Ratio1.90%
Quick Ratio0.88%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$84.25 million
Price / Sales0.30
Cash FlowN/A
Price / CashN/A
Book Value($1.90) per share
Price / Book-1.31

Profitability

Trailing EPS($19.79)
Net Income$-83,440,000.00
Net Margins-79.45%
Return on Equity-1,177.11%
Return on Assets-74.29%

Miscellaneous

Employees591
Outstanding Shares10,120,000

Tandem Diabetes Care (NASDAQ:TNDM) Frequently Asked Questions

What is Tandem Diabetes Care's stock symbol?

Tandem Diabetes Care trades on the NASDAQ under the ticker symbol "TNDM."

When did Tandem Diabetes Care's stock split? How did Tandem Diabetes Care's stock split work?

Tandem Diabetes Care shares reverse split before market open on Tuesday, October 10th 2017. The 1-10 reverse split was announced on Monday, October 9th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, October 9th 2017. An investor that had 100 shares of Tandem Diabetes Care stock prior to the reverse split would have 10 shares after the split.

How were Tandem Diabetes Care's earnings last quarter?

Tandem Diabetes Care Inc (NASDAQ:TNDM) released its earnings results on Thursday, October, 26th. The medical device company reported ($3.09) EPS for the quarter, topping analysts' consensus estimates of ($3.74) by $0.65. The medical device company had revenue of $27 million for the quarter, compared to the consensus estimate of $25.92 million. Tandem Diabetes Care had a negative net margin of 79.45% and a negative return on equity of 1,177.11%. The firm's revenue for the quarter was up 119.7% on a year-over-year basis. During the same quarter in the prior year, the business earned ($0.97) EPS. View Tandem Diabetes Care's Earnings History.

When will Tandem Diabetes Care make its next earnings announcement?

Tandem Diabetes Care is scheduled to release their next quarterly earnings announcement on Tuesday, March, 6th 2018. View Earnings Estimates for Tandem Diabetes Care.

Where is Tandem Diabetes Care's stock going? Where will Tandem Diabetes Care's stock price be in 2017?

6 analysts have issued twelve-month price objectives for Tandem Diabetes Care's shares. Their predictions range from $3.00 to $17.00. On average, they expect Tandem Diabetes Care's stock price to reach $13.00 in the next year. View Analyst Ratings for Tandem Diabetes Care.

Who are some of Tandem Diabetes Care's key competitors?

Who are Tandem Diabetes Care's key executives?

Tandem Diabetes Care's management team includes the folowing people:

  • Dick P. Allen, Independent Chairman of the Board (Age 72)
  • Kim D. Blickenstaff, President, Chief Executive Officer, Director (Age 64)
  • John Cajigas, Chief Financial Officer, Executive Vice President, Treasurer (Age 51)
  • John F. Sheridan, Chief Operating Officer, Executive Vice President (Age 61)
  • David B. Berger Esq., Executive Vice President, General Counsel, Secretary (Age 47)
  • Brian B. Hansen, Chief Commercial Officer, Executive Vice President (Age 49)
  • Susan M. Morrison, Chief Administrative Officer (Age 37)
  • Edward L. Cahill, Independent Director (Age 61)
  • Fred E. Cohen Ph.D. M.D., Independent Director (Age 60)
  • Howard E. Greene Jr., Independent Director (Age 74)

Who owns Tandem Diabetes Care stock?

Tandem Diabetes Care's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Frontier Capital Management Co. LLC (96.38%), Wasatch Advisors Inc. (31.04%), Russell Investments Group Ltd. (6.52%), Keybank National Association OH (4.25%) and Wedbush Securities Inc. (3.76%). Company insiders that own Tandem Diabetes Care stock include Dick Allen, John F Sheridan and Kim D Blickenstaff. View Institutional Ownership Trends for Tandem Diabetes Care.

Who sold Tandem Diabetes Care stock? Who is selling Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was sold by a variety of institutional investors in the last quarter, including Keybank National Association OH, Frontier Capital Management Co. LLC and Wasatch Advisors Inc.. View Insider Buying and Selling for Tandem Diabetes Care.

Who bought Tandem Diabetes Care stock? Who is buying Tandem Diabetes Care stock?

Tandem Diabetes Care's stock was bought by a variety of institutional investors in the last quarter, including Wedbush Securities Inc. and Russell Investments Group Ltd.. Company insiders that have bought Tandem Diabetes Care stock in the last two years include Dick Allen and Kim D Blickenstaff. View Insider Buying and Selling for Tandem Diabetes Care.

How do I buy Tandem Diabetes Care stock?

Shares of Tandem Diabetes Care can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Tandem Diabetes Care's stock price today?

One share of Tandem Diabetes Care stock can currently be purchased for approximately $2.48.

How big of a company is Tandem Diabetes Care?

Tandem Diabetes Care has a market capitalization of $25.09 million and generates $84.25 million in revenue each year. The medical device company earns $-83,440,000.00 in net income (profit) each year or ($19.79) on an earnings per share basis. Tandem Diabetes Care employs 591 workers across the globe.

How can I contact Tandem Diabetes Care?

Tandem Diabetes Care's mailing address is 11045 ROSELLE STREET, San Diego CA, 92121. The medical device company can be reached via phone at 858-366-6900 or via email at [email protected]


MarketBeat Community Rating for Tandem Diabetes Care (TNDM)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  156 (Vote Outperform)
Underperform Votes:  188 (Vote Underperform)
Total Votes:  344
MarketBeat's community ratings are surveys of what our community members think about Tandem Diabetes Care and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Tandem Diabetes Care (NASDAQ:TNDM) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: HoldHoldHoldHold
Consensus Rating Score: 2.442.402.272.27
Ratings Breakdown: 0 Sell Rating(s)
5 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
1 Sell Rating(s)
6 Hold Rating(s)
4 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $27.14$32.43$60.71$60.71
Price Target Upside: 826.38% upside5,480.55% upside527.80% upside527.80% upside

Tandem Diabetes Care (NASDAQ:TNDM) Consensus Price Target History

Price Target History for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ:TNDM) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/19/2017Robert W. BairdReiterated RatingHold$3.00N/AView Rating Details
10/10/2017WedbushReiterated RatingOutperform$50.00 -> $17.00N/AView Rating Details
10/6/2017Piper Jaffray CompaniesReiterated RatingHold$15.00N/AView Rating Details
5/3/2017B. RileyReiterated RatingNeutral$15.00MediumView Rating Details
4/10/2017CowenDowngradeOutperform -> Market Perform$15.00MediumView Rating Details
3/9/2017Northcoast ResearchReiterated RatingBuyN/AView Rating Details
11/2/2016Deutsche BankLower Price TargetBuy$140.00 -> $90.00N/AView Rating Details
11/2/2016Feltl & Co.DowngradeStrong-Buy -> BuyN/AView Rating Details
11/2/2016Stifel NicolausDowngradeBuy -> Hold$150.00 -> $35.00N/AView Rating Details
5/16/2016Sterne Agee CRTReiterated RatingNeutralN/AView Rating Details
3/24/2016Bank of AmericaDowngradeNeutral -> UnderperformN/AView Rating Details
(Data available from 12/13/2015 forward)

Earnings

Tandem Diabetes Care (NASDAQ:TNDM) Earnings History and Estimates Chart

Earnings by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
3/6/2018($2.45)N/AView Earnings Details
10/26/2017Q3 2017($3.74)($3.09)$25.92 million$27.00 millionViewN/AView Earnings Details
7/27/2017Q2 2017($4.80)($4.40)$21.74 million$21.30 millionViewN/AView Earnings Details
4/27/2017Q1 2017($6.60)($7.50)$15.72 million$17.50 millionViewN/AView Earnings Details
3/8/2017Q4 2016($6.50)($4.80)$22.75 million$24.80 millionViewListenView Earnings Details
7/28/2016Q216($6.50)($6.00)$23.08 million$23.00 millionViewListenView Earnings Details
4/28/2016Q116($6.90)($6.80)$17.67 million$20.06 millionViewN/AView Earnings Details
2/24/2016Q415($5.10)($4.00)$29.17 million$29.10 millionViewListenView Earnings Details
10/29/2015Q3($8.00)($6.50)$12.58 million$15.70 millionViewListenView Earnings Details
7/30/2015Q215($7.10)($6.50)$14.92 million$15.70 millionViewListenView Earnings Details
4/30/2015Q115($7.90)($8.30)$12.19 million$12.30 millionViewN/AView Earnings Details
2/24/2015Q414($8.10)($7.80)$17.16 million$17.90 millionViewN/AView Earnings Details
11/6/2014Q314($8.20)($8.50)$13.60 million$13.50 millionViewN/AView Earnings Details
7/31/2014Q214($9.10)($8.30)$10.36 million$10.26 millionViewN/AView Earnings Details
5/6/2014Q1($6.90)($9.60)$8.24 million$8.10 millionViewN/AView Earnings Details
11/8/2011$2.50$1.80ViewN/AView Earnings Details
8/9/2011$2.60$2.00ViewN/AView Earnings Details
5/10/2011$2.40$2.40ViewN/AView Earnings Details
3/14/2011$2.90$1.80ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Tandem Diabetes Care (NASDAQ:TNDM) Earnings Estimates

2017 EPS Consensus Estimate: ($3.17)
2018 EPS Consensus Estimate: ($1.17)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20175($0.81)($0.62)($0.71)
Q2 20174($0.63)($0.37)($0.46)
Q3 20174($3.82)($0.33)($1.25)
Q4 20175($2.81)($0.21)($0.76)
Q1 20182($0.34)($0.34)($0.34)
Q2 20182($0.34)($0.28)($0.31)
Q3 20182($0.28)($0.28)($0.28)
Q4 20182($0.28)($0.20)($0.24)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Tandem Diabetes Care (NASDAQ:TNDM)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Tandem Diabetes Care (NASDAQ TNDM) Insider Trading and Institutional Ownership History

Insider Ownership Percentage: 20.90%
Insider Trades by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)
Institutional Ownership by Quarter for Tandem Diabetes Care (NASDAQ:TNDM)

Tandem Diabetes Care (NASDAQ TNDM) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
10/13/2017Kim D BlickenstaffCEOBuy285,700$3.50$999,950.00View SEC Filing  
3/23/2017Kim D BlickenstaffCEOBuy1,600,000$1.25$2,000,000.00View SEC Filing  
8/1/2016John F SheridanEVPSell15,000$6.52$97,800.00View SEC Filing  
5/2/2016John F SheridanCOOSell2,000$10.61$21,220.00View SEC Filing  
4/22/2016John F SheridanCOOSell2,000$10.00$20,000.00View SEC Filing  
3/7/2016John F SheridanCOOSell4,000$10.01$40,040.00View SEC Filing  
2/26/2016Dick AllenDirectorBuy10,000$8.24$82,400.00View SEC Filing  
12/1/2015John F. SheridanCOOSell2,000$10.14$20,280.00View SEC Filing  
11/2/2015John F. SheridanCOOSell4,000$10.00$40,000.00View SEC Filing  
9/14/2015John F. SheridanCOOSell2,000$12.51$25,020.00View SEC Filing  
5/1/2015John F SheridanCOOSell2,000$13.72$27,440.00View SEC Filing  
4/1/2015John F SheridanCOOSell2,000$12.47$24,940.00View SEC Filing  
2/2/2015John F SheridanCOOSell2,000$12.06$24,120.00View SEC Filing  
1/2/2015John F SheridanCOOSell2,000$12.75$25,500.00View SEC Filing  
12/12/2014Dick AllenDirectorBuy10,000$11.95$119,500.00View SEC Filing  
12/1/2014John F SheridanCOOSell2,000$13.55$27,100.00View SEC Filing  
11/3/2014John F SheridanCOOSell2,000$16.00$32,000.00View SEC Filing  
10/1/2014John F SheridanCOOSell2,000$13.07$26,140.00View SEC Filing  
9/2/2014John F SheridanCOOSell2,000$13.99$27,980.00View SEC Filing  
8/1/2014John F SheridanCOOSell2,000$15.04$30,080.00View SEC Filing  
7/1/2014John F SheridanCOOSell2,000$16.42$32,840.00View SEC Filing  
6/18/2014John F SheridanCOOSell2,000$16.75$33,500.00View SEC Filing  
11/13/2013David B BergerGeneral CounselBuy2,000$15.00$30,000.00View SEC Filing  
11/13/2013Hlm Venture Partners Ii, L.P.Major ShareholderBuy200,000$15.00$3,000,000.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Tandem Diabetes Care (NASDAQ TNDM) News Headlines

Source:
DateHeadline
Tandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research to HoldTandem Diabetes Care (TNDM) Downgraded by Zacks Investment Research to Hold
www.americanbankingnews.com - December 13 at 10:20 AM
Tandem Diabetes Care (TNDM) Upgraded to "Buy" at Zacks Investment ResearchTandem Diabetes Care (TNDM) Upgraded to "Buy" at Zacks Investment Research
www.americanbankingnews.com - December 10 at 6:28 AM
Zacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Announce Quarterly Sales of $34.36 MillionZacks: Brokerages Anticipate Tandem Diabetes Care Inc (TNDM) Will Announce Quarterly Sales of $34.36 Million
www.americanbankingnews.com - December 9 at 2:44 AM
Tandem Diabetes Care Announces Retirement of CFO and ... - Business Wire (press release)Tandem Diabetes Care Announces Retirement of CFO and ... - Business Wire (press release)
www.businesswire.com - December 8 at 11:26 AM
Tandem Diabetes Care Announces Retirement of CFO and Successor AppointmentTandem Diabetes Care Announces Retirement of CFO and Successor Appointment
finance.yahoo.com - December 8 at 11:26 AM
-$1.30 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter-$1.30 Earnings Per Share Expected for Tandem Diabetes Care Inc (TNDM) This Quarter
www.americanbankingnews.com - December 7 at 9:36 PM
ETFs with exposure to Tandem Diabetes Care, Inc. : November 29, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : November 29, 2017
finance.yahoo.com - November 29 at 3:50 PM
$34.36 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter$34.36 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter
www.americanbankingnews.com - November 22 at 1:46 PM
Tandem Diabetes Care, Inc. (TNDM) PT Lowered to $2.00 at Bank of America CorporationTandem Diabetes Care, Inc. (TNDM) PT Lowered to $2.00 at Bank of America Corporation
www.americanbankingnews.com - November 20 at 2:52 PM
Reviewing Zimmer Biomet Holdings (ZBH) and Tandem Diabetes Care (TNDM)Reviewing Zimmer Biomet Holdings (ZBH) and Tandem Diabetes Care (TNDM)
www.americanbankingnews.com - November 20 at 1:30 AM
 Analysts Anticipate Tandem Diabetes Care, Inc. (TNDM) Will Announce Earnings of -$1.30 Per Share Analysts Anticipate Tandem Diabetes Care, Inc. (TNDM) Will Announce Earnings of -$1.30 Per Share
www.americanbankingnews.com - November 20 at 1:28 AM
Tandem Diabetes Care, Inc. (TNDM) Rating Reiterated by Robert W. BairdTandem Diabetes Care, Inc. (TNDM) Rating Reiterated by Robert W. Baird
www.americanbankingnews.com - November 19 at 7:36 PM
Tandem Diabetes Care, Inc. (TNDM) Receives Consensus Recommendation of "Hold" from BrokeragesTandem Diabetes Care, Inc. (TNDM) Receives Consensus Recommendation of "Hold" from Brokerages
www.americanbankingnews.com - November 19 at 7:54 AM
Tandem Diabetes Care to Present at the 29th Annual Piper Jaffray Healthcare ConferenceTandem Diabetes Care to Present at the 29th Annual Piper Jaffray Healthcare Conference
finance.yahoo.com - November 18 at 9:31 AM
ETFs with exposure to Tandem Diabetes Care, Inc. : November 17, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : November 17, 2017
finance.yahoo.com - November 18 at 9:31 AM
Tandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference - Business Wire (press release)Tandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference - Business Wire (press release)
www.businesswire.com - November 9 at 8:17 AM
Tandem Diabetes Care to Present at the Stifel 2017 Healthcare ConferenceTandem Diabetes Care to Present at the Stifel 2017 Healthcare Conference
finance.yahoo.com - November 7 at 8:33 PM
ETFs with exposure to Tandem Diabetes Care, Inc. : November 6, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : November 6, 2017
finance.yahoo.com - November 7 at 12:11 PM
Human Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump with Automated Insulin Delivery FeatureHuman Factors Research Presented at DTM 2017 Demonstrates Ease of Use and Effectiveness of Computer-Based Training for Touchscreen Insulin Pump with Automated Insulin Delivery Feature
finance.yahoo.com - November 5 at 7:32 AM
Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration,Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration,
www.nasdaq.com - November 2 at 9:56 AM
Analysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated ResultsAnalysis: Positioning to Benefit within Tandem Diabetes Care, CASI Pharmaceuticals, SAExploration, Roka Bioscience, VirnetX, and PhaseRx – Research Highlights Growth, Revenue, and Consolidated Results
finance.yahoo.com - November 2 at 9:56 AM
$35.30 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter$35.30 Million in Sales Expected for Tandem Diabetes Care, Inc. (TNDM) This Quarter
www.americanbankingnews.com - November 1 at 1:54 PM
Tandem Diabetes Care, Inc. (TNDM) Stock Rating Upgraded by Zacks Investment ResearchTandem Diabetes Care, Inc. (TNDM) Stock Rating Upgraded by Zacks Investment Research
www.americanbankingnews.com - November 1 at 11:56 AM
Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017Tandem Diabetes Care, Inc. :TNDM-US: Earnings Analysis: Q3, 2017 By the Numbers : November 1, 2017
finance.yahoo.com - November 1 at 9:45 AM
 Analysts Expect Tandem Diabetes Care, Inc. (TNDM) to Announce -$2.65 EPS Analysts Expect Tandem Diabetes Care, Inc. (TNDM) to Announce -$2.65 EPS
www.americanbankingnews.com - October 30 at 1:24 PM
Tandem Diabetes Cares (TNDM) CEO Kim Blickenstaff on Q3 2017 Results - Earnings Call TranscriptTandem Diabetes Care's (TNDM) CEO Kim Blickenstaff on Q3 2017 Results - Earnings Call Transcript
seekingalpha.com - October 28 at 2:42 AM
Tandem Diabetes Care EPS of -$3.09Tandem Diabetes Care EPS of -$3.09
seekingalpha.com - October 27 at 4:31 PM
ETFs with exposure to Tandem Diabetes Care, Inc. : October 27, 2017ETFs with exposure to Tandem Diabetes Care, Inc. : October 27, 2017
finance.yahoo.com - October 27 at 4:30 PM
Tandem Diabetes Care, Inc. (TNDM) Issues Quarterly  Earnings ResultsTandem Diabetes Care, Inc. (TNDM) Issues Quarterly Earnings Results
www.americanbankingnews.com - October 27 at 3:40 PM
Tandem Diabetes Care Reports Third Quarter 2017 Financial Results - Business Wire (press release)Tandem Diabetes Care Reports Third Quarter 2017 Financial Results - Business Wire (press release)
www.businesswire.com - October 27 at 6:57 AM
Tandem Diabetes Care Reports Third Quarter 2017 Financial ResultsTandem Diabetes Care Reports Third Quarter 2017 Financial Results
finance.yahoo.com - October 27 at 6:57 AM
Tandem Diabetes reports 3Q lossTandem Diabetes reports 3Q loss
finance.yahoo.com - October 27 at 6:57 AM
Edited Transcript of TNDM earnings conference call or presentation 26-Oct-17 8:30pm GMTEdited Transcript of TNDM earnings conference call or presentation 26-Oct-17 8:30pm GMT
finance.yahoo.com - October 27 at 6:57 AM
Tandem Diabetes Care, Inc. to Host Earnings CallTandem Diabetes Care, Inc. to Host Earnings Call
finance.yahoo.com - October 26 at 10:25 AM
Tandem Diabetes Care to Provide All t:slim X2 Insulin Pump Features Approved in 2018 to Users at No Cost and Expands Existing Dexcom Welcome Offer for Animas CustomersTandem Diabetes Care to Provide All t:slim X2 Insulin Pump Features Approved in 2018 to Users at No Cost and Expands Existing Dexcom Welcome Offer for Animas Customers
finance.yahoo.com - October 25 at 5:01 PM
Tandem Diabetes Care, Inc. (TNDM) Receives Consensus Rating of "Hold" from AnalystsTandem Diabetes Care, Inc. (TNDM) Receives Consensus Rating of "Hold" from Analysts
www.americanbankingnews.com - October 25 at 8:44 AM
Tandem Diabetes Care, Inc. (TNDM) Set to Announce Earnings on MondayTandem Diabetes Care, Inc. (TNDM) Set to Announce Earnings on Monday
www.americanbankingnews.com - October 23 at 5:38 AM
Reviewing Tandem Diabetes Care (TNDM) and The CompetitionReviewing Tandem Diabetes Care (TNDM) and The Competition
www.americanbankingnews.com - October 21 at 6:20 AM
Wednesday 10/18 Insider Buying Report: TNDM, ODC - NasdaqWednesday 10/18 Insider Buying Report: TNDM, ODC - Nasdaq
www.nasdaq.com - October 19 at 9:51 AM
Tandem Diabetes Care, Inc. (TNDM) CEO Purchases $999,950.00 in StockTandem Diabetes Care, Inc. (TNDM) CEO Purchases $999,950.00 in Stock
www.americanbankingnews.com - October 17 at 7:26 PM
Tandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference CallTandem Diabetes Care Schedules Third Quarter 2017 Earnings Press Release and Conference Call
finance.yahoo.com - October 17 at 8:12 AM
Tandem Diabetes (TNDM) Prices 4.63M Share Common Offering at $3.50/ShTandem Diabetes (TNDM) Prices 4.63M Share Common Offering at $3.50/Sh
www.streetinsider.com - October 15 at 7:38 AM
Tandem Diabetes Care prices equity offering; shares down 31% premarketTandem Diabetes Care prices equity offering; shares down 31% premarket
seekingalpha.com - October 15 at 7:38 AM
7 Stocks To Watch For October 13, 2017 - Benzinga7 Stocks To Watch For October 13, 2017 - Benzinga
www.benzinga.com - October 14 at 8:39 AM
Health Care Sector Update for 10/13/2017: TNDM,PZRX,ATRS - NasdaqHealth Care Sector Update for 10/13/2017: TNDM,PZRX,ATRS - Nasdaq
www.nasdaq.com - October 14 at 8:39 AM
Mid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares Plunge - BenzingaMid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares Plunge - Benzinga
www.benzinga.com - October 14 at 8:39 AM
Mid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares PlungeMid-Day Market Update: Crude Oil Up Over 1%; Tandem Diabetes Care Shares Plunge
feeds.benzinga.com - October 13 at 2:16 PM
Tandem Diabetes Care sees ~$27M in Q3 sales; shares down 30% premarket on proposed equity offeringTandem Diabetes Care sees ~$27M in Q3 sales; shares down 30% premarket on proposed equity offering
seekingalpha.com - October 13 at 9:22 AM
Tandem Diabetes (TNDM) Plans Offering of Common Stock, Series A Warrants and Series B WarrantsTandem Diabetes (TNDM) Plans Offering of Common Stock, Series A Warrants and Series B Warrants
www.streetinsider.com - October 13 at 9:22 AM
Tandem Diabetes Care (TNDM) Is Falling After Offering AnnouncementTandem Diabetes Care (TNDM) Is Falling After Offering Announcement
www.rttnews.com - October 13 at 9:22 AM

SEC Filings

Tandem Diabetes Care (NASDAQ:TNDM) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Tandem Diabetes Care (NASDAQ:TNDM) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Tandem Diabetes Care (NASDAQ TNDM) Stock Chart for Wednesday, December, 13, 2017

Loading chart…

This page was last updated on 12/13/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.